Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 594,697
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $56,737,885
Total People Sold 5 5 6 7
Total Sell Transactions 11 15 24 53
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1213
  Page 19 of 49  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lapalme Pierre Director   –       •      –    2012-02-28 4 S $36.01 $720,106 D/D (20,000) 21,250     -
   Lapalme Pierre Director   –       •      –    2012-02-28 4 OE $8.47 $169,400 D/D 20,000 41,250     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-02-24 4 S $35.07 $2,911,989 D/D (83,036) 40,104     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-02-24 4 OE $14.39 $1,541,801 D/D 83,036 123,140     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-02-24 4 S $34.84 $3,180,989 D/D (91,313) 83,493     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-02-24 4 OE $6.13 $980,499 D/D 91,313 174,806     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-02-24 4 S $35.07 $175,325 D/D (5,000) 8,300     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-02-24 4 OE $11.74 $58,700 D/D 5,000 13,300     -
   Grey Michael G Director   –       •      –    2012-02-23 4 D $35.36 $1,060,785 D/D (30,000) 16,250     -
   Grey Michael G Director   –       •      –    2012-02-23 4 OE $16.92 $507,600 D/D 30,000 46,250     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-02-23 4 S $35.31 $176,541 D/D (5,000) 121,093     -
   Wood Mark VP, Human Resources   •       –      –    2012-02-22 4 AS $35.14 $65,149 D/D (1,854) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2012-02-22 4 OE $14.39 $32,905 D/D 1,854 22,488     -
   Wood Mark VP, Human Resources   •       –      –    2012-01-23 4 AS $34.96 $64,821 D/D (1,854) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2012-01-23 4 OE $14.39 $32,898 D/D 1,854 22,488     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-01-03 4 AS $34.75 $86,880 D/D (2,500) 40,104     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-01-03 4 OE $14.39 $35,975 D/D 2,500 42,604     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-01-03 4 AS $34.75 $86,883 D/D (2,500) 36,611     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-01-03 4 OE $11.05 $27,625 D/D 2,500 39,111     -
   Wood Mark VP, Human Resources   •       –      –    2011-12-22 4 AS $33.79 $62,647 D/D (1,854) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-12-22 4 OE $14.39 $32,902 D/D 1,854 22,488     -
   Wood Mark VP, Human Resources   •       –      –    2011-11-22 4 AS $32.18 $59,697 D/D (1,855) 20,634     -
   Wood Mark VP, Human Resources   •       –      –    2011-11-22 4 OE $14.39 $32,920 D/D 1,855 22,489     -
   Baffi Robert EVP, Technical Operations   •       –      –    2011-11-14 4 GA $0.00 $0 I/I 333 4,482     -
   Baffi Robert EVP, Technical Operations   •       –      –    2011-11-14 4 GD $0.00 $0 D/D 333 56,106     -
  1213 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 49
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us